StockData
Adicet Bio, Inc. logo

Adicet Bio, Inc. (ACET) stock

ACETNasdaqPharmaceutical PreparationsFiscal year ends December 26
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 5/30
$2.93−0.06 (-2.01%)

Close on Nov 12, 2026Market cap $27.43MP/E –Yield –

Adicet Bio statistics

68 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings
Mar 11, 2027 (estimated, during market hours)
Last ex-dividend date
No dividends
Fundamentals through
Sep 30, 2026
Share price as of
Nov 12, 2026

Valuation ratiosIndustry

Market Cap
$27.43M
$280.48M
Enterprise Value
$318.17K
$148.62M
PB Ratio
0.27
2.05
P/TBV Ratio
0.27
2.29

Share statisticsIndustry

Shares Change (YoY)
87.5%
10.9%
Shares Change (QoQ)
0.00%
0.48%
Float
715,571
49M
Shares Held by Insiders
92.4%
12.1%
Shares Held by Institutions
65.3%
56.4%

Short sellingIndustry

Short Interest
459,550
–
Short Interest Change
-11.9%
-0.76%
Short % of Float
64.2%
9.06%
Short % of Shares Outstanding
4.91%
6.30%
Days to Cover
2.57
5.13

Stock price statisticsIndustry

52-Week High
$11.20
–
52-Week Low
$2.84
–
20-Day Moving Average
$3.61
–
50-Day Moving Average
$6.07
–
200-Day Moving Average
$7.45
–
Average True Range (14)
$0.35
–
Price Change (1 Week)
0.34%
1.51%
Price Change (1 Month)
-40.1%
-2.37%
Price Change (3 Months)
-65.0%
-21.1%
Price Change (6 Months)
-65.2%
-22.8%
Price Change (YTD)
-65.2%
-22.6%
Price Change (1 Year)
-71.7%
-21.0%
Price Change (3 Years)
-84.5%
-24.8%
Price Change (5 Years)
-98.1%
-76.9%
Average Volume (10 Days)
298,186
–
Average Volume (20 Days)
236,282
–
Average Volume (90 Days)
189,341
–
Relative Volume
1.99
0.80
Relative Strength Index (14)
18.8
44.7
Volatility (1 Year)
75.1%
80.2%
Beta (5 Years)
1.66
1.07

Returns on capitalIndustry

Return on Equity (ROE)
-85.9%
-51.3%
Return on Assets (ROA)
-67.5%
-40.7%
Return on Invested Capital (ROIC)
-97.0%
-32.9%
Return on Capital Employed (ROCE)
-85.4%
-38.1%

Financial positionIndustry

Current Ratio
6.09
3.31
Quick Ratio
1.60
2.41
Interest Coverage
-1038.62
-6.35

EfficiencyIndustry

Profits Per Employee
-$892.12K
-$683.67K
Employee Count
102
75
WACC
13.2%
10.0%

Income statement (TTM)Industry

Operating Income
-$95.55M
-$20.99M
Pretax Income
-$90.85M
-$13.23M
Net Income
-$91.00M
-$21.61M
EBITDA
-$90.54M
-$16.85M
EPS (Diluted)
-$8.56
-$0.75

Balance sheetIndustry

Net Cash (Debt)
$27.11M
$16.98M
Net Cash Per Share
$2.90
$0.72
Equity (Book Value)
$102.70M
$52.68M
Book Value Per Share
$10.97
$1.50
Tangible Book Value
$102.70M
$26.74M
Working Capital
$86.45M
$78.52M

Cash flow (TTM)Industry

Operating Cash Flow
-$80.14M
-$12.27M
Capital Expenditures
-$285.00K
-$944.00K
Free Cash Flow
-$80.43M
-$18.20M
FCF Per Share
-$8.59
-$0.42

Dividends and yieldsIndustry

Earnings Yield
-331.7%
-21.0%
FCF Yield
-293.2%
-9.44%

Taxes and interestIndustry

Interest Expense
$92.00K
$2.97M
Income Tax
$144.00K
$74.00K

Scores and fair valueIndustry

Altman Z-Score
-8.34
0.26
Piotroski F-Score
2
4

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.

PeriodACETS&P 500DifferenceACET per yearS&P 500 per year
1 month-47.0%-2.7%−44.3 pts
3 months-64.5%-1.7%−62.8 pts
Year to date-65.2%+11.9%−77.1 pts
1 year-73.3%+12.0%−85.3 pts
3 years-84.7%+78.2%−162.9 pts-46.6%+21.2%
5 years-98.1%+73.2%−171.4 pts-54.8%+11.6%

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

0M ACET shares were sold short on Oct 30, 2026, down 11.9% from the previous report, or 64.22% of the shares available to trade. At recent volumes it would take 2.6 days to buy them back. Over the last 20 sessions, 37.3% of the volume reported to FINRA was short selling.

Settlement dateShares shortChangeAvg. daily volumeDays to cover
Oct 30, 2026459,550-11.9%178,7522.6
Oct 15, 2026521,883+7.5%222,5952.3
Sep 30, 2026485,466+78.5%439,5131.1
Sep 15, 2026271,989+7.6%131,0752.1
Aug 31, 2026252,663-3.7%104,5082.4
Aug 14, 2026262,357-33.9%82,7573.2
Jul 31, 2026397,053+3.6%91,9514.3
Jul 15, 2026383,174-24.2%89,4054.3
Jun 30, 2026505,580+0.9%96,2125.3
Jun 15, 2026501,254-3.2%75,7386.6
May 29, 2026517,922-11.9%124,7484.2
May 15, 2026587,837+6.2%103,4575.7

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?